Review Article

Potential Role of Exosomes in Mending a Broken Heart: Nanoshuttles Propelling Future Clinical Therapeutics Forward

Table 1

Exosomes isolated from stem cells derived from rodent source and their cardioprotective effects on the heart post-MI.

Source cells (rodents)Conditions for Exo generationIn vivo modelDose/route of administrationOutcomesReferences

ESC40 h in culture—unclear about serum statusMouse, MI10 μg total Exo protein/inj; IM inj into border zone at 2 sites↑ LVEF
↑ FS
↓ ESD
↓ infarct size
Khan et al. [38]

BM-MSCO/N glucose starvation, (±)IPC; serum-free, collected after 48 hMouse, MIμg total Exo protein; injected along border zone↓ infarct size with IPCFeng et al. [51]
10% Exo-depleted FBS, collected after 48 h; during passage 4Rat, MI20 μg total Exo protein into 2 sides along infarct border zone↑ LVEF
↑ FS
↓ fibrosis
↓ inflammation
Shao et al. [50]
Overexpression of GATA4, 10% Exo-free FBS, collected after 48 hRat, MIExo from 4 × 106 cells; IM injection at border zone↑ LVEF
↑ FS
↓ infarct size
Yu et al. [37]

Rat heart perfusate(±)IPCRat, Langendorff I/RPerfused prior to 30 min global ischemia, 2 h reperfusion↓ infarct size with IPC perfusateGiricz et al. [52]

CPC2% Exo-depleted FBS, collected after 48 hMouse, MIHalf of Exo collected from 5 × 105 cells; IM injection↓ apoptosisChen et al. [82]

CD31+ cardiac ECOverexpression of HIF-1α, Exo-depleted serumMouse, MI25 μg total Exo protein ± 1 × 106 CPCs; peri-infarct injection↑ LVEF
↑ FS
↓ Infarct size
↑ capillary density
↑ survival of transplanted CPCs
Ong et al. [36]

ESC: embryonic stem cell; BM-MSC: bone marrow-derived mesenchymal stem cell; CPC: cardiac progenitor cell; EC: endothelial cell; MI: myocardial infarction; Exo: exosome; inj: injection; IM: intramyocardial; IPC: ischemic preconditioning; LVEF: left ventricular ejection fraction; FS: fractional shortening; ESD: end systolic diameter; O/N: overnight.